3rd Quarter - Report

VENABLE LLP for AMERICAN UROLOGICAL ASSOCIATION

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2026 Defense Appropriations funding for Bladder Cancer and Kidney Cancer; FY 2026 Labor Health & Human Services and Education Funding for National Institute of Health; Drug shortages

LobbyistCovered position, as disclosed
JOHN V. DRZEWICKI —
LAURA A HANEN —
JIM TWADDELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Specialty Physicians Advancing Rural Care Act (H.R. 4681 / S. 1380); PSA screening for HIM Act (H.R. 1300 / S. 297); Medicare physician payment issues; Telehealth policy issues; Price authorization issues; Medicine Patient Access & Practice Stabilization Act (H.R. 879); Public questions for the record on Senate U.S. Department of Health and Human Services confirmation hearings.

LobbyistCovered position, as disclosed
DEEPTI LOHARIKAR —
JIM TWADDELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1300 (119th), S. 297 (119th), H.R. 879 (119th), H.R. 4681 (119th), S. 1380 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.